CL, K., EE, F., CL, T., DS, P., KC, V., & P, S. (2015). Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Scientific reports, 5, 12911. https://doi.org/10.1038/srep12911
Chicago Style (17th ed.) CitationCL, Kurtz, Fannin EE, Toth CL, Pearson DS, Vickers KC, and Sethupathy P. "Inhibition of MiR-29 Has a Significant Lipid-lowering Benefit Through Suppression of Lipogenic Programs in Liver." Scientific Reports 5 (2015): 12911. https://doi.org/10.1038/srep12911.
MLA (9th ed.) CitationCL, Kurtz, et al. "Inhibition of MiR-29 Has a Significant Lipid-lowering Benefit Through Suppression of Lipogenic Programs in Liver." Scientific Reports, vol. 5, 2015, p. 12911, https://doi.org/10.1038/srep12911.